2Raymond E,Eaivre S,Woynarowski JM,et al.Oxalipltin:Mechanism of action and antineop lastic activeyl[J].Sermin Oncol,1998,25(5):4212.
3Zaniboni A,Meriqqi F.The emerging role of oxaliplatin in the treament of gastric cancer[J].J Chemother,2005,17(6):656.
4Cassidy J,Clarke S,D az-Ruio E,et al.Randomized phase Ⅲ study of capecitabine plus oxaliolatin as first-line therapy for metastatic colorectal cancer[J].J clin Oncol,2008,26(12):2006.
5Porschen R,Arkenau HT,Kubicks S,et al.phase Ⅲ study of capecitabine plus oxaliplatin in metastatic colorectal cancer:a final report of the AIO Colorectal Study Group[J].J Clin Oncol,2007,25(27):4217.
6Miwa M,Vra M,Nishida M,et al.Design of anovel oral fluoropyrimidine carbamate,capecitabine with generates 5-fluorouracil selectively in tumours by enzymes concentrated inhuman liver and cancer tissue[J].
7孙燕,周际昌.临床肿瘤内科手册[M].第6版.北京:人民卫生出版社,2006:583.
8Sumpter K,Harper-Wynne C,Cunningham D,et al.Report of two protocol planned in terim analyses in a randomized multiceenter phase Ⅲ study comparing capecitabine with fluorouracil and oxaliptatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF[J].Br J Cancer,2005,92(11):1976.
5Krejs G J. Gastric cancer: epidemiology and risk factors[J]. Dig Dis, 2010, 28(4-5): 600-603.
6Yang D, Hendifar A, Lenz C, et al. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity[J]. J Gastrointest Oncol, 2011, 2(2): 77-84.
7Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer[J]. Br J Surg, 2013, 100(1): 55-65.
8Cervantes A, Roda D, Tarazona N, et al. Current questions for the treatment of advanced gastric cancer[J]. Cancer Treat Rev, 2013, 39(1): 60-67.
9Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test[J]. BMJ, 1997, 315(7109): 629-634.
10Francesco M, Gina T, Claudio M, et al. Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis[J]. Gastric Cancer, 2011, 14(1): 50-55.
